Key result
Female sex was associated with similar mortality to men in chronic thromboembolic pulmonary hypertension despite older age and less frequent invasive treatments.
Why the study?
Clinical presentation, disease distribution, and treatment differences may explain sex differences in chronic thromboembolic pulmonary hypertension (CTEPH).
Do clinical presentation, treatment patterns, and survival differ by sex in patients with chronic thromboembolic pulmonary hypertension?
Observational (n=453)
No
Do clinical presentation, treatment patterns, and survival differ by sex in patients with chronic thromboembolic pulmonary hypertension?
In CTEPH, despite women presenting with worse baseline characteristics and receiving less invasive treatment, their mortality is similar to men, with recent treatment advances potentially driving survival benefits in women.
(1) Background: Clinical presentation, disease distribution, or treatment received may provide insights into the reasons contributing to sex differences in chronic thromboembolic pulmonary hypertension (CTEPH). (2) Methods: We evaluated 453 patients (56% women) between 2007-2019. Data was collected from REHAP (Registro Español de Hipertensión Arterial Pulmonar) registry. Two time periods were selected to evaluate the influence of new treatments over time. (3) Results: Women were older. Baseline functional class was worse, and distance walked shorter in women compared with men. Women had higher pulmonary vascular resistances. Despite this, pulmonary endarterectomy (PEA) was carried out in more men, and women received more frequently pulmonary vasodilators exclusively. The 2014-2019 interval was associated with a better survival only among women. Interestingly, women had a more distal disease during this second period of time. (4) Conclusions: Even though women were older, and received invasive treatments less frequently, mortality was similar in both sexes. The introduction of balloon pulmonary angioplasty and the improvement of pulmonary endarterectomy, especially during the last years, could be associated with a survival benefit among women.
No takes yet. Share an insight, caveat, or question.
Cruz‐Utrilla et al. (2021) conducted an observational in chronic thromboembolic pulmonary hypertension (CTEPH) (n=453). Female sex vs. Male sex was evaluated on Mortality. Female sex was associated with similar mortality to men in chronic thromboembolic pulmonary hypertension despite older age and less frequent invasive treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: